All Posts: breast cancer
-
Neurologic Drug Combined with Blood Pressure Medicine Reduces Breast Tumor Development in Mice
WASHINGTON (December 30, 2019) — Adding a medication used to treat epilepsy, bipolar disorder and migraines to a blood pressure medicine reversed some aspects of breast cancer in the offspring of mice at high risk of the disease because of the high-fat diet fed to their mothers during pregnancy. Conversely, this treatment combination increased breast […]
Category: News Release
-
Palbociclib is Safe for Women with Advanced Breast Cancer Who Have Unique Gene Alteration
WASHINGTON (December 11, 2019) — Women who receive palbociclib (Ibrance®) to treat their advanced breast cancer and have a gene alteration that can lead to a condition known as benign ethnic neutropenia (BEN) can safely receive the drug without major concerns of developing infections associated with neutropenia, or low white blood cell counts, say Georgetown Lombardi […]
Category: News Release
-
DC Community Out in Strength to Support Capital Breast Care Center
(October 25, 2019) — More than 100 local community advocates and patients gathered October 25 for the 12th Annual Gift of Life Breakfast benefiting Georgetown Lombardi Comprehensive Cancer Center’s C
Category: Lombardi Stories
-
Tipo Agressivo de Câncer de Mama é Influenciado pela Ação Conjunta de Genes e RNA
Mulheres Latinas são frequentemente diagnosticadas em estágios avançados de câncer de mama do tipo triplo-negativo e podem se beneficiar de tratamentos que tem como alvo a biologia de seus tumores. WASHINGTON (22 de outubro de 2019) — Mulheres diagnosticadas com um tipo menos comum e agressivo de câncer de mama, conhecido como triplo-negativo, podem ser diferenciadas […]
Category: News Release
-
Aggressive Form of Breast Cancer Influenced by Dual Action of Genes and RNA
Latina women are typically diagnosed with aggressive triple-negative breast cancer at late stages and could benefit from treatments targeted to the biology of their disease. Media Contact: Kar
Category: News Release
-
Mammography Unlikely to Benefit Older Women with Chronic Illnesses
A new study by a group of researchers including Dejana Braithwaite, PhD, from Georgetown Lombardi indicates that regular screening mammograms are unlikely to benefit women 75 and older who have chronic illnesses.
Category: News Release
-
Walking Warriors Second Annual Walk Raises More Than 35,000 for Breast Cancer
The Walking Warriors Battling Breast Cancer’s second-annual walk on April 27 raised more than 35,000 for breast cancer research, community service and education programs at Georgetown Lombardi Comprehensive Cancer Center.
Category: Lombardi Stories
-
Genetic Testing in Women Diagnosed with Breast Cancer Decreases Cost of Care Nationwide
A new study by Georgetown Lombardi Comprehensive Cancer Center and National Cancer Institute researchers suggests that Oncotype DX-guided treatment could reduce the cost for the first year of breast cancer care in the U.S. by about $50 million and offer women valuable information about treatment options.
Category: News Release
-
Genetic Testing of Women Diagnosed with Breast Cancer Could Be 'Impactful'
Claudine Isaacs, MD, a Georgetown Lombardi medical oncologist, weighs in on new guidelines issued by the American Society of Breast Surgeons.
Category: Lombardi Stories
-
Jill Biden Joins Washington Area Anchorwomen to Raise Funds for Georgetown’s Capital Breast Care Center
Former second lady of the United States Jill Biden joined supporters, survivors, politicos and friends for the annual NewsBash event, which helps raise awareness for breast cancer and this year raised funds for Georgetown’s Capital Breast Care Center.
Category: Lombardi Stories